Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;1(5):797-800.
doi: 10.3892/ol_00000139. Epub 2010 Sep 1.

A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes

Affiliations

A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes

Walid Al Achkar et al. Oncol Lett. 2010 Sep.

Abstract

The so-called Philadelphia (Ph) chromosome is present in more than 90% of chronic myeloid leukemia (CML) patients. Around 5-10% of these patients show complex translocations involving other chromosomes in addition to and/or besides chromosomes 9 and 22. CML cases with fusion transcripts, such as e13a3, in which ABL exon 3 rather than exon 2 has fused to BCR, are extremely rare. Such reported cases with the e13a3 transcript showed the Ph chromosome on karyotype analysis. This study reported a rare Ph chromosome-positive CML case with new complex chromosomal aberrations and an e13a3 BCR-ABL transcript that has yet to be established. A four-chromosome translocation involving chromosomal regions 12p11.2, 19q13.3, 9q34.1 and 22q11.2, besides a trisomy 8 and a derivative chromosome 12, were identified using high resolution multicolor banding. Reverse transcription polymerase chain reaction products showed the presence of BCR-ABL fusion transcript e13a3, and this signifies the major BCR breakpoint. The significance of the observed rearrangements and their possible role in the progression of CML was investigated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
GTG-banding revealed a complex karyotype involving two further chromosomes besides chromosomes 9 and 22. Derivative chromosomes are indicated by the arrowheads.
Figure 2
Figure 2
Karyotype and chromosomal aberrations were confirmed using molecular cytogenetic approaches. (A) M-FISH confirmed the complexity of the karyotype: 48,XX,+8,+der(12),t(9;12),t(12;19),t(19;22). (B-E) The application of aMCB analysis using probe sets for chromosomes 9, 12, 19 and 22 is shown. The normal chromosomes are shown to the left of the image, and the derivative of the four chromosomes to the middle and right. Using aMCB probes, the light gray areas show unstained regions on the derivative chromosomes. (F) Fluorescence in situ hybridization (FISH) using probes for BCR (green) and ABL (red) confirmed the involvement of chromosome 19 in the rearrangement present in this case. #, chromosome; der, derivative chromosome; Ph, Philadelphia chromosome.
Figure 3
Figure 3
Gel electrophoresis of the nested RT-PCR products. Lane M, 501-110 bp marker; lane 1, negative control; lane 2, positive control (b3a2, 353 bp); lane 3, β2-microglobuline (535 bp); lane 4, BCR-ABL (b2a3, 104 bp) from the patient and lane 5, M½100 bp molecular weight marker.

Similar articles

Cited by

References

    1. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature. 1985;315:550–554. - PubMed
    1. Deiningger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343–3356. - PubMed
    1. Al-Ali HK, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger MW. CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood. 2002;100:1092–1093. - PubMed
    1. Liu LG, Tanaka H, Ito K, Kyo T, Ito T, Kimura A. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3. Am J Hematol. 2003;74:268–272. - PubMed
    1. Snyder DS, McMahon R, Cohen SR, Slovak ML. Chronic myeloid leukemia with e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory. Am J Hematol. 2004;75:92–95. - PubMed

LinkOut - more resources